%0 Journal Article
%9 ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES
%A Ridde, Valéry
%A Ba, M. F.
%A Gaye, I.
%A Diallo, A. I.
%A Bonnet, Emmanuel
%A Faye, A.
%T Participating in a vaccine trial for COVID-19 in Senegal : trust and information
%D 2021
%L fdi:010082596
%G ENG
%J Human Vaccines and Immunotherapeutics
%@ 2164-5515
%K Vaccine trial ; COVID-19 ; Senegal ; acceptability ; participation
%K SENEGAL
%M ISI:000674817900001
%N 11
%P 3907-3912
%R 10.1080/21645515.2021.1951097
%U https://www.documentation.ird.fr/hor/fdi:010082596
%> https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2022-09/010082596.pdf
%V 17
%W Horizon (IRD)
%X This research aims to understand the level and determinants of people's willingness to participate in a vaccine trial for COVID-19 in Senegal. We conducted a telephone survey among a marginal quota sample of 607 people over 18 years of age. Only 44.3% of the participants wanted to participate in a vaccine trial for COVID-19, with females intending to participate more than males (AOR = 1.82, 95% CI [1.22-2.72]). Participants who intended to be vaccinated against COVID-19 (AOR = 6.48, 95% CI [4.12-10.4]) and who thought that being infected with the coronavirus would have a significant impact on their health (AOR = 2.34, 95% CI [1.57, 3.51]) were more likely to agree to take part in the COVID-19 vaccine trial. Confidence in the vaccine, health personnel, and the government in the fight against the pandemic are key factors in participants' willingness to participate in a vaccine trial in Senegal.
%$ 052 ; 050 ; 056